Multiband study of RX J0838-2827 and XMM J083850.4-282759: A new asynchronous magnetic cataclysmic variable and a candidate transitional millisecond pulsar

Indexación: Scopus.In a search for the counterpart to the Fermi-LAT source 3FGL J0838.8-2829, we performed a multiwavelength campaign: in the X-ray band with Swift and XMM-Newton; in the infrared and optical with OAGH, ESO-NTT and IAC80; and in the radio with ATCA observations. We also used archival hard X-ray data obtained by INTEGRAL. We report on three X-ray sources consistent with the position of the Fermi-LAT source.We confirm the identification of the brightest object, RX J0838-2827, as a magnetic cataclysmic variable that we recognize as an asynchronous system (not associated with the Fermi-LAT source). RX J0838-2827 is extremely variable in the X-ray and optical bands, and timing analysis reveals the presence of several periodicities modulating its X-ray and optical emission. The most evident modulations are interpreted as being caused by the binary system orbital period of ~1.64 h and the white dwarf spin period of ~1.47 h. A strong flux modulation at ~15 h is observed at all energy bands, consistent with the beat frequency between spin and orbital periods. Optical spectra show prominent Hß, He I and He II emission lines that are Doppler-modulated at the orbital period and at the beat period. Therefore, RX J0838-2827 accretes through a disc-less configuration and could be either a strongly asynchronous polar or a rare example of a pre-polar system on its way to reaching synchronism. Regarding the other two X-ray sources, XMM J083850.4-282759 showed a variable X-ray emission, with a powerful flare lasting for ~600 s, similar to what is observed in transitional millisecond pulsars during the subluminous disc state: this observation possibly means that this source can be associated with the Fermi-LAT source. © 2017 The Authors.https://academic.oup.com/mnras/article/471/3/2902/408195

Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence:A Tamoxifen Exemestane Adjuvant Multinational Study Analysis

textabstractIntroduction. For postmenopausal patients with hormonesensitive breast cancer, outcome is worse with increasing age at diagnosis. The aim of this study was to assess the incidenceof breast cancer recurrence (locoregionalanddistant), and contralateral breast cancer by age at diagnosis. Methods. Patients enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial were included. Primary endpoints were locoregional recurrence, distant recurrence, and contralateralbreastcancer.Ageatdiagnosiswascategorizedas younger than 65 years, 65-74 years, and 75 years or older. Results. Overall, 9,766 patients were included, of which 5,349 were younger than 65 years (reference group), 3,060 were 65-74 years, and 1,357 were 75 years or older. With increasing age, a decreased administration of radiotherapy after breast conserving surgery (94%, 92%, and 88%, respectively) and adjuvant chemotherapy (51%, 23%, and 5%, respectively) was observed. Risk of distant recurrence increased with age at diagnosis; multivariable hazard ratio for patients aged 65-74 years was 1.20 (95% confidence interval [CI]: 1.00 -1.44), hazard ratio for patients aged 75 years or older was 1.39 (95% CI: 1.08 -1.79). Risks of locoregional recurrence and contralateral breast cancer were not significantly different across age groups. Conclusion. Elderly patients with breast cancer were at increased risk for distant recurrence. Other studies have shown that the risk of distant recurrence is mainly affected by adjuvant systemic therapy. All TEAM patients received adjuvant endocrine treatment; however, chemotherapy was administered less often in elderly patients. These findings are suggestive for consideration of chemotherapy in relatively fit elderly breast cancer patients with hormonesensitive disease